La actualidad en Seguridad del Paciente en un clic: últimos tuits de @sanoysalvoblog

(Drug Safety) Allopurinol Hypersensitivity: A Systematic Review of All Published Cases, 1950–2012 http://t.co/DWSQ5KbwWY#PtSafety
— Sano y salvo (@sanoysalvoblog) July 22, 2013

Scientific Evidence and Controversies About Pioglitazone and Bladder Cancer: Which Lessons Can Be Drawn? http://t.co/1vqvUzPeUO#PtSafety
— Sano y salvo (@sanoysalvoblog) July 22, 2013

RT @polimedlabs De la Seguridad del Paciente en Atención Primaria http://t.co/0YxpFJIneN#SegPac
— Sano y salvo (@sanoysalvoblog) July 22, 2013

“@DTB_BMJ: Tramadol painkiller could be banned from public sale, say ministers http://t.co/UZvQFbA6ci via @guardian” #PtSafety
— Sano y salvo (@sanoysalvoblog) July 22, 2013

“@vmontori: Corruption of healthcare: Big pharma mobilising patients in battle over drugs trials data http://t.co/vp4apfQylV via @guardian”
— Sano y salvo (@sanoysalvoblog) July 22, 2013

Please sign the #AllTrials petition: All clinical pharma trials registered & all results reported http://t.co/RC1bws8mr1
— Sano y salvo (@sanoysalvoblog) July 22, 2013

(WeMeReC) RAM y farmacovigilancia, conceptos generales http://t.co/rEP10E8khU#SegPac
— Sano y salvo (@sanoysalvoblog) July 23, 2013

“@AdverseEvent: American Diabetes Association Findings Show Older Patients at High Risk for Adverse Events http://t.co/HyvyRKOFFg” #PtSafety
— Sano y salvo (@sanoysalvoblog) July 23, 2013

La FDA investiga dos muertes tras inyección con antipsicótico de larga duración Zypadhera (pamoato de olanzapina) http://t.co/JFz5ukM91g
— Farmacia DA Oeste AP (@FarmaciaOesteAP) July 24, 2013

UK Government: Consultation on prescription drug tramadol https://t.co/fZmjmtbv3S#PtSafety
— Sano y salvo (@sanoysalvoblog) July 24, 2013

Cancer Incidence Among Those Initiating Insulin Therapy With Glargine Versus Human NPH Insulin http://t.co/Fu7wrjOLKg#PtSafety
— Sano y salvo (@sanoysalvoblog) July 24, 2013

(Drug Safety) Drug-Induced Thrombosis: An Update http://t.co/fumKUFhNOk#PtSafety
— Sano y salvo (@sanoysalvoblog) July 24, 2013

Danish Pharmacovigilance: Acute pancreatitis and hepatitis associated with the use of vildagliptin and linagliptin http://t.co/BcvD3ATs1g
— Sano y salvo (@sanoysalvoblog) July 24, 2013

Danish Pharmacovigilance: Reports of adverse reactions from the use of Gardasil during the period 2009-2012 (pp 6-11) http://t.co/BcvD3ATs1g
— Sano y salvo (@sanoysalvoblog) July 24, 2013

El 32% de los pacientes con fibrilación auricular tratados con anticoagulantes orales están mal controlados http://t.co/C7tBpZ5PdT#SegPac
— Txema Coll (@txemacoll) July 24, 2013

(NHS Choices) Decongestant sprays linked to rare birth defects http://t.co/qgAlOcQP2T#PTSafety
— Sano y salvo (@sanoysalvoblog) July 25, 2013

Curso de Experto Universitario en Seguridad del Paciente, on-line 30 ECTS @uned 4ª convocatoria http://t.co/ppm17wxdOC
— Seguridad Paciente (@seguridadpacien) July 7, 2013

The time-efficiency principle: time as the key diagnostic strategy in primary care http://t.co/JX4HsWwWIC#PtSafety v @enriquegavilan
— Sano y salvo (@sanoysalvoblog) July 25, 2013

Prescripción responsable. Para leer con calma, hoy en NEJM http://t.co/nNCznTo1Zb vía @JesusmRedondo
— Prescripc Prudente (@PrescripcP) July 25, 2013

RT @EMA_News No new concerns for #GLP-1 therapies identified on the basis of available evidence: http://t.co/woPKHQ1Pp8#PtSafety
— Sano y salvo (@sanoysalvoblog) July 26, 2013

RT @EMA_News We recommend suspension of marketing authorisations for oral #ketoconazole: http://t.co/4hryR60Tx4#PtSafety
— Sano y salvo (@sanoysalvoblog) July 26, 2013

RT @EMA_News We recommend changes to the use of #metoclopramide: http://t.co/3foCCy2dWX#PtSafety
— Sano y salvo (@sanoysalvoblog) July 26, 2013

Blog CADIME: Seguridad comparada de estatinashttp http://t.co/flrKj4BokJ#SegPac
— Sano y salvo (@sanoysalvoblog) July 26, 2013

RT @rafabravo Top 10 Patient-Safety Strategies Update http://t.co/zN8vSLbiCk#PtSafety
— Sano y salvo (@sanoysalvoblog) July 26, 2013

“@pediamecum: Informe 2012 sobre EudraVigilance, base de datos sobre sospechas de efectos adversos de medicamentos  http://t.co/NJX2oDIWQn”
— Sano y salvo (@sanoysalvoblog) July 26, 2013

La agencia francesa propone retirar la bromocriptina para suprimir la lactancia #SegPachttp://t.co/qCDpraWE3f
— Sano y salvo (@sanoysalvoblog) July 27, 2013